Genexine Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genexine Inc with three other
companies in this sector in South Korea:
sales of 23.81 billion Korean Won [US$21.14 million]
of which 58%
Legochem Biosciences Inc
(22.06 billion Korean Won [US$19.59 million]
(23.27 billion Korean Won [US$20.66 million]
Sales increased substantially in 2017:
Genexine Inc reported sales of 28.45 billion Korean Won (US$25.27 million)
December of 2017.
increase of 150.7%
versus 2016, when the company's sales were 11.35 billion Korean Won.
Despite this increase, sales are still
below the level achieved in 2015, when Genexine Inc
reported sales of 32.52 billion Korean Won.